High-quality
real-world data

Generating high-validity real-world evidence requires high-quality RWD.

Accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas using credible evidence developed from high-quality real-world data with unrivaled richness and reliability.

High-quality
real-world data

Generating high-validity real-world evidence requires high-quality RWD.

Accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas using credible evidence developed from high-quality real-world data with unrivaled richness and reliability.

New times call for a powerful platform

For life sciences decision-makers, Verantos is making what seemed impossible, possible. Our high-validity RWE platform provides curation, linkage, and enrichment to provide the richest and most reliable RWD at scale in the industry.

quotation mark

Generate evidence your stakeholders will trust

Unrivaled clinical richness, proven reliability

star

Our Awards

Rank 189 in North America Verantos reached #224 on the 2022 Inc 5000 list Partner logo
image alt testing

Meet increasing RWE demands

High-validity RWE – generated from the entire patient record – makes it possible to understand how patient characteristics and behaviors affect health outcomes to predict the progression of a disease and a patient’s responses to therapy while also increasing the efficiency of R&D investments and accelerating time to market.

Magnifying Glass Icon

Get out of the danger zone

Studies based on traditional RWE leave franchises vulnerable to regulatory and market access concerns and commercial delay. High-validity studies run on our high-validity RWE platform provide accurate and believable evidence, enabling regulatory and reimbursement approvals. It is worth investing now in the RWE capabilities of the future.

Our products

Pragmatic Registry

Pragmatic Registry is a disease-specific registry of subjects generated from routinely collected, real-world data.

  • Clinically rich data from the entire patient record incorporates variables that are rarely or never coded in structured data
  • Measurable industry-leading data reliability enabling high-validity evidence generation facilitates clinical assertions to support clinician, payer, and regulator decision-making
  • Registry data are normalized and delivered in standardized OMOP CDM format, ready for use.

A few of our partners

Partner logo Partner logo Partner logo Bayer Partner logo Partner logo Partner logo

Credible evidence is a competitive advantage.

Credible evidence is a competitive advantage.